VBIV - VBI Vaccines Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
4,331
3,355
865
548
Cost of Revenue
6,547
4,509
5,193
3,671
Gross Profit
-2,216
-1,154
-4,328
-3,123
Operating Expenses
Research Development
32,071
38,467
20,918
9,966
Selling General and Administrative
26,453
20,787
12,034
11,761
Total Operating Expenses
58,524
59,254
32,952
21,727
Operating Income or Loss
-60,740
-60,408
-37,280
-24,850
Interest Expense
3,146
3,254
2,882
-
Total Other Income/Expenses Net
-35
-560
736
189
Income Before Tax
-63,188
-63,600
-39,426
-24,985
Income Tax Expense
0
0
-431
-1,780
Income from Continuing Operations
-63,188
-63,600
-38,995
-23,205
Net Income
-63,188
-63,600
-38,995
-23,205
Net Income available to common shareholders
-63,188
-63,600
-38,995
-23,205
Reported EPS
Basic
-
-0.97
-0.88
-0.77
Diluted
-
-0.97
-0.88
-0.77
Weighted average shares outstanding
Basic
-
65,648
44,159
30,044
Diluted
-
65,648
44,159
30,044
EBITDA
-
-59,804
-36,550
-24,244